Quebec-based Medicago begins late-stage study of COVID-19 vaccine

Canadian drug developer Medicago said on Tuesday it had started a late-stage study of its experimental COVID-19 vaccine combined with a booster from GlaxoSmithKline . View original article here Source

Recommended For You

About the Author: GetFit